A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
Stopped early · Phase 2
Conditions studied: Gastric Cancer, Gastric Adenocarcinoma, GastroEsophageal Cancer
In brief
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Key facts
- Study ID
- NCT04363801
- Run by
- Leap Therapeutics, Inc.
- People needed
- 247
- Starts
- 2020-07-29
- Expected to finish
- 2025-03-31
- Last updated by the study team
- 2025-10-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Cancer Center — Phoenix, Arizona, United States
- University of Arizona — Tucson, Arizona, United States
- City of Hope — Duarte, California, United States
- The Angeles Clinic Research Institute - A Cedars-Sinai Affiliate — Los Angeles, California, United States
- University of Southern California — Los Angeles, California, United States
- UCLA — Los Angeles, California, United States
- Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
- Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California, United States
- University of California San Francisco — San Francisco, California, United States
- Mayo Clinic Florida — Jacksonville, Florida, United States
- AdventHealth Cancer Institute — Orlando, Florida, United States
- Northwestern University Robert H. Lurie Comprehensive Cancer Center — Chicago, Illinois, United States
- University of Chicago — Chicago, Illinois, United States
- Pontchartrain Cancer Center — Covington, Louisiana, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Columbia University Irving Medical Center — New York, New York, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- University of Wisconsin Carbone Cancer Center — Madison, Wisconsin, United States
- Charité Universitätsmedizin Berlin — Berlin, Germany
- Institut Fur Klinisch Onkologische Forschung Am Krankenhaus Nordwest — Frankfurt, Germany
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.